Testing effectiveness (Phase 2)WithdrawnNCT00821561
What this trial is testing
Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
Who this might be right for
Persistent Epithelial Defect
OcuNexus Therapeutics, Inc. 90